SEATTLE-- (BUSINESS WIRE)-- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software company Biomage.

SEATTLE, January 07, 2025--(BUSINESS WIRE)--Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today announced a significant expansion of its Evercode™ WT ...

Seattle-based Parse will gain 10 employees through the acquisition. Seattle-based startup Parse Biosciences has acquired Biomage, an analysis software company based in Glasgow, Scotland.

SEATTLE, December 19, 2024 -- (BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a ...

As part of the agreement, Parse admitted that 10x Genomics' ATAC-seq patents are valid, enforceable, and had been infringed by Parse's use of ATAC-seq methods and compositions.

Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome the South Australian Genomics Centre (SAGC) as the newest member of its Certified Service ...

Karen L. Pascale of Young Conaway Stargatt & Taylor has entered an appearance for Parse Biosciences Inc. in a pending patent lawsuit asserting three patents for single-cell sequencing technology ...

SEATTLE, February 19, 2025--Parse Biosciences today announced the first single cell RNA sequencing kits to profile 5 million cells and 384 samples in a single run.

INTEGRA Biosciences and Parse Biosciences have partnered to automate single cell RNA sequencing (scRNA-seq) on the ASSIST PLUS pipetting robot.

SEATTLE, December 19, 2024 -- (BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a premier ...